Nicholas Investment Partners, LP 908 Devices Inc. Transaction History

Nicholas Investment Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$13.3 - $20.74 $12,049 - $18,790	-906 Reduced 0.16%	551,895 $11.4 Million
Q1 2022 May 10, 2022	BUY	$13.18 - $26.28 $3.2 Million - $6.39 Million	242,968 Added 78.42%	552,801 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$23.17 - $38.77 $510,157 - $853,637	22,018 Added 7.65%	309,833 $8.02 Million
Q3 2021 Nov 15, 2021	SELL	$29.99 - $39.13 $2.1 Million - $2.74 Million	-70,043 Reduced 19.57%	287,815 $9.36 Million
Q2 2021 Aug 10, 2021	BUY	$36.7 - $55.11 $1.77 Million - $2.66 Million	48,224 Added 15.57%	357,858 $13.9 Million

Q1 2021 May 14, 2021	BUY	$39.94 - $75.0 $8.63 Million - $16.2 Million	216,039 Added 230.82%	309,634 $15 Million
Q4 2020 Feb 11, 2021	BUY	$49.0 - $67.92 $4.59 Million - $6.36 Million	93,595 New	93,595 $5.33 Million

20.7M

39.4K

38.9K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $149M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.